Krystal Biotech KRYS Cash Flow Statement (2016-2026)

NASDAQ KRYS
$308.81 +2.31 (+0.75%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Krystal Biotech Quarterly Cash Flow Statement

Periods 41 quarters
Latest Sep 2026

Krystal Biotech reported cash from operations of $91.25M and free cash flow of $90.25M for the quarter ended Sep 2026, up 130.1% year over year. This cash flow statement covers 41 quarters of results from Sep 2016 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-21.81M-49.97M-28.11M-29.85M-32.05M-45.30M-33.21M80.75M8.69M0.93M15.57M27.18M45.48M35.73M38.33M79.37M51.40M55.93M54.77M63.07M
Depreciation and DepletionDep. & Depletion
0.45M0.46M0.49M0.67M1.04M1.10M1.20M1.20M1.51M1.43M1.80M1.30M1.40M1.41M1.30M1.40M1.52M1.52M1.40M1.50M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.78M1.02M0.98M0.98M1.09M0.71M1.04M0.83M1.51M1.43M1.80M1.30M1.40M1.41M1.30M1.40M1.52M1.52M1.40M1.50M
Share-based CompensationStock Comp.
5.15M6.43M8.19M9.06M9.55M10.44M11.33M8.31M9.85M9.30M13.16M13.32M13.36M13.48M14.12M13.15M13.76M13.61M14.16M13.94M
Deferred Taxes
1.84M
Gains from Sales and DivestituresGains Divest
14.51M-14.53M100.00M1.40M-0.07M-0.71M-0.62M1.22M-0.78M0.22M
Gains from Investment SecuritiesGains Investment
0.81M1.58M1.50M1.21M1.21M1.65M1.57M1.64M1.50M2.75M1.29M0.40M0.53M0.75M0.48M
Other non-cash itemsOther Non-Cash
1.41M-0.39M-0.22M-0.31M-0.37M-0.62M-0.12M-0.24M0.02M-0.23M0.65M0.21M-0.30M-0.37M0.79M0.22M
Change in Working Capital
Change in ReceivablesChange Receivables
9.32M32.72M4.43M56.77M-5.94M7.45M-1.49M8.18M17.92M-2.49M-0.06M11.97M-5.43M
Change in InventoryChange Inventory
0.91M3.08M0.49M2.24M-0.53M3.68M6.52M1.40M-0.88M4.71M1.06M0.24M0.96M2.00M
Change in Account PayablesChange Payables
0.94M-0.55M0.58M-0.34M-0.94M0.11M0.37M-0.36M-0.22M0.73M0.78M0.09M-0.59M0.91M4.12M-4.02M-0.18M1.02M3.06M0.22M
Change in Accrued ExpensesChange Accrued Exp.
-4.02M2.01M0.46M0.54M2.16M-3.46M1.80M2.54M3.68M-5.16M1.13M1.94M7.48M3.70M-1.29M5.92M5.79M-6.31M5.44M3.40M
Change in TaxesChange Taxes
-0.97M0.46M-1.41M-9.16M-2.29M3.37M-4.67M6.77M
Change in Other Operating AssetsOther Assets Change
1.66M-0.83M-0.03M-0.14M1.62M0.17M0.37M-0.03M1.10M0.21M2.29M-0.52M5.31M3.43M-1.42M2.30M-2.04M1.70M0.19M3.78M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.05M-0.13M-0.16M-0.17M-0.19M-0.17M-0.22M0.70M4.83M5.11M10.83M7.77M7.70M11.00M4.95M4.32M2.71M13.89M14.92M4.26M
Other Working Capital ChangesOther WC Changes
-1.71M0.70M-0.13M-0.04M-1.80M-0.34M-0.58M0.72M3.73M4.90M8.53M8.30M2.39M7.57M6.37M2.02M4.75M12.19M14.72M0.48M
Other Operating Activities (as filed)
-0.23M-0.14M-0.03M-0.06M0.26M0.00M0.05M-0.13M0.29M-0.24M0.33M0.64M-0.07M0.61M0.08M-0.30M0.29M0.14M0.17M-0.49M
Cash from OperationsCash from Ops.
-20.90M-15.49M-43.06M-19.69M-22.33M-26.16M-34.19M-21.23M-7.23M15.89M-4.17M58.86M52.84M30.97M52.73M39.66M77.51M80.38M74.79M91.25M
Investing Activities
Capital ExpendituresCapex
40.88M17.19M16.52M14.06M5.22M5.38M2.79M1.78M1.85M1.26M1.13M1.05M0.80M6.20M1.90M1.70M2.14M7.15M3.57M1.00M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.44M
Change in Property, Plant and EquipmentChange in PP&E
-40.88M-17.19M-16.52M-14.06M-5.22M-5.38M-2.79M-1.78M-1.85M-1.26M-1.13M-1.05M-0.80M-5.77M-1.90M-1.70M-2.14M-7.15M-3.57M-1.00M
Purchase of InvestmentsInvestments Purchased
137.81M113.90M98.37M-700.16M160.03M258.02M194.04M
Sale and Maturity of InvestmentsInvestments Sold
21.00M24.04M62.79M66.77M104.08M154.52M161.23M112.87M74.59M63.62M95.18M79.25M60.50M88.81M105.28M95.79M85.76M103.60M100.00M137.05M
Cash from Investing ActivitiesCash from Investing
-126.54M-55.91M-38.22M-14.74M-5.21M3.56M-15.96M105.19M-10.16M-25.98M-19.35M-34.33M-83.78M-54.77M-10.53M-4.29M11.16M-63.58M-161.58M-57.98M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Net Long-Term Debt Issued (Repaid)Net LT Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
202.07M0.11M30.70M2.12M3.07M2.22M185.27M13.39M2.62M15.97M10.64M3.37M2.43M1.46M1.80M3.71M15.69M6.50M15.16M3.42M
Net Shares Issued and RepurchasedNet Shares Issued
202.07M0.11M30.70M2.12M3.07M2.22M185.27M13.39M2.62M15.97M10.64M3.37M2.43M1.46M1.80M3.71M15.69M6.50M15.16M3.42M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
202.07M0.11M30.70M2.12M3.07M2.22M185.27M13.39M2.62M15.97M10.64M3.37M2.43M1.46M1.80M3.71M15.69M6.50M15.16M3.42M
Other financing activities (as filed)
-0.65M-0.75M-5.39M-13.93M-0.01M-0.02M-16.96M-0.11M-0.01M
Cash from Financing ActivitiesCash from Financing
202.07M-0.54M30.70M2.12M3.07M1.47M185.27M13.39M2.62M10.58M10.64M3.37M2.43M-12.47M1.80M3.71M15.67M-10.46M15.05M3.41M
Additional items
Exchange Rate EffectFX Effect
-0.04M-0.04M0.01M0.01M-0.14M0.19M-0.34M0.29M-0.59M0.17M1.06M-0.31M-0.64M-1.33M-1.83M-1.58M
Change in Cash
54.63M-71.94M-50.58M-32.31M-24.51M-21.16M135.13M97.37M-14.91M0.68M-13.22M28.18M-29.10M-36.10M45.06M38.78M103.70M5.01M-73.57M35.10M
Ending Cash Balance
341.25M269.30M218.72M186.41M161.90M140.75M275.88M373.24M358.33M359.01M345.79M373.97M344.87M308.77M353.83M392.60M496.30M501.31M427.74M462.84M
Free Cash FlowFCF
-61.78M-32.68M-59.57M-33.74M-27.55M-31.54M-36.98M-23.01M-9.08M14.63M-5.30M57.81M52.04M24.77M50.83M37.96M75.37M73.23M71.22M90.25M
Net Cash FlowNCF
54.63M-71.94M-50.58M-32.31M-24.47M-21.12M135.12M97.35M-14.77M0.49M-12.88M27.89M-28.51M-36.27M44.00M39.08M104.34M6.34M-71.74M36.68M
Income Taxes PaidTaxes Paid
2.00M3.15M0.52M0.40M13.46M0.02M1.80M0.63M13.20M8.90M

Krystal Biotech Cash Flow Statement API

Pull Krystal Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=KRYS&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY